Chinese companies to supply 110M COVID-19 vaccines immediately to COVAX project

0 Comment(s)Print E-mail Xinhua, July 13, 2021
Adjust font size:
Photo taken on June 1, 2021 shows vials of Sinopharm vaccines in Beijing, capital of China. [Photo/Xinhua]

Chinese pharmaceutical companies will provide 110 million doses of COVID-19 vaccines immediately to participants of the COVAX project, announced the global Vaccine Alliance Gavi on Monday.

The Chinese Sinopharm and Sinovac vaccines have been approved earlier this year by the World Health Organization (WHO) for emergency use.

Gavi announced in a press release that it had signed advance purchase agreements with Sinopharm for its "BBIBP-CorV" inactivated virus vaccine and with Sinovac for its inactivated virus vaccine "CoronaVac".

The agreements, which come at a time when the Delta variant of the virus is posing a rising risk, will begin to make 110 million doses immediately available to participants of the COVAX Facility, the international vaccine supply and distribution facility co-led by WHO, Gavi and other partners, read the press release.

"Thanks to this deal, and because these vaccines have already received WHO Emergency Use Listing, we can move to start supplying doses to countries immediately," said Gavi CEO Seth Berkley. 

Follow on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from